Is This The Calm Before The Storm On Arrowhead Pharmaceuticals, Inc. (ARWR)?

Arrowhead Pharmaceuticals, Inc. (ARWR) has seen some recent volatility in the stock market and its shares closed trading at $58.88 yesterday. Investors are starting to take notice of ARWR as the shares traded as high as $59.03 and as low as $57.35 in the previous market day.

Arrowhead Pharmaceuticals, Inc. (ARWR) average trading volume is 1.50M. However, in the previous market day Arrowhead Pharmaceuticals, Inc. (ARWR) exchanged 1,351,364 shares. The First downside support level on ARWR is $56.03. ARWR 50-day moving average is $45.07 and ARWR two hundred day moving average is $40.98.

Arrowhead Pharmaceuticals, Inc. (ARWR) most current performance has been specified by the recent movement in ARWR shares. ARWR has performed 32.88% over the past 4 weeks, ARWR has performed 21.80% over the past 3 months and ARWR has shown 59.70% over the past 1 year. Arrowhead Pharmaceuticals, Inc. (ARWR) has a 52 week range of $19.51 to $73.72. Arrowhead Pharmaceuticals, Inc. (ARWR) is trading 201.79% from its 52 week low and -20.13% from its 52 week high. Arrowhead Pharmaceuticals, Inc. (ARWR) is displaying a 9.05% short float displaying the quantity short in the float.

ARWR has 101.84M shares outstanding and 99.57M shares in the float. Arrowhead Pharmaceuticals, Inc. (ARWR) presently has a market cap of $5.99B and income of -24.40M. The EPS next quarter for ARWR is 0.11 and projected EPS next year is -133.30%. The market cap of Arrowhead Pharmaceuticals, Inc. (ARWR) at $5.99B represents how many Investors own shares of ARWR and is calculated off the last price ($58.88) of ARWR and the quantity of shares outstanding (101.84M) with Arrowhead Pharmaceuticals, Inc. (ARWR).

Arrowhead Pharmaceuticals, Inc. (ARWR) has total cash (mrq) of 287.03M, total cash per share (mrq) of 2.81, total debt of ARWR rests at 21.37M and total debt/equity (mrq) is 4.34. . Arrowhead Pharmaceuticals, Inc. (ARWR) running cash flow (ttm) is -70.73M, ARWR leveraged free cash flow (ttm) is -66.8M.

ARWR is trading 23.31% above (bullish) its SMA20, 34.70% above (bullish) its SMA50 and 47.90% above (bullish) its SMA200.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...